For patients with prostate cancer, long-term follow-up helps identify treatment side effects.

Published Date: 24 Jan 2024

A 10-year retrospective analysis involving nearly 2,500 U.S. S. Men who have undergone treatment for prostate cancer will contribute to the knowledge base when it comes to treatment options and side effects for a wide range of people.

Read Full News

Latest News


News All Time

Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

Patients with chronic myeloid leukemia who take nilotinib are at higher risk for diabetes and hyperlipidemia.

2.

High-speed whole-body SPECT tracks tumor evolution to optimize prostate cancer treatment

3.

Atezolizumab + Cabozantinib Postpones mCRPC Progression.

4.

Frontline Decisions in Transplant-Ineligible Multiple Myeloma: Evaluating Quadruplet Therapy

5.

Checking PSA levels too soon after prostate cancer surgery can lead to overtreatment, study suggests


© Copyright 2026 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
bot